Clinical Trials Directory

Trials / Completed

CompletedNCT05008991

Lung Functions in Menopausal Obese Women After COVID 19 Recovery

Assessment of Lung Functions in Menopausal Obese Women After COVID 19 Recovery

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Badr University · Academic / Other
Sex
Female
Age
45 Years – 55 Years
Healthy volunteers
Accepted

Summary

The COVID-19 pandemic has presented considerable challenges to global health services and dictates almost every aspect of medical practice and policy. The menopausal transition may have significant consequences for respiratory health as COVID 19 symptoms subsides, lung function testing should be done to assess the consequences of this virus on lung health especially in menopausal woman.

Detailed description

The study group will consist of (40) obese menopausal women whom were recently recovered from mild-moderate COVID 19 for one month. The control group will consist of (40) obese menopausal women; whom will not affected by COVID 19. Using incentive spirometer, we will measure forced vital capacity FVC, forced expiratory volume FEV, Tiffano index TI and peak expiratory force PEF in both groups.

Conditions

Interventions

TypeNameDescription
DEVICESpirometrySpirometry assesses the integrated mechanical function of the lung, chest wall, respiratory muscles, and airways by measuring the total volume of air exhaled from a full lung (total lung capacity \[TLC\]) to maximal expiration (residual volume \[RV\]). This volume, the forced vital capacity (FVC) and the forced expiratory volume in the first second of the forceful exhalation (FEV1), should be repeatable to within 0.15 L upon repeat efforts in the same measurement unless the largest value for either parameter is less than 1 L. In this case, the expected repeatability is to within 0.1 L of the largest value.

Timeline

Start date
2021-07-20
Primary completion
2021-09-20
Completion
2021-10-20
First posted
2021-08-17
Last updated
2021-11-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05008991. Inclusion in this directory is not an endorsement.